Shaanxi Panlong Pharmaceutical Group Co., Ltd. (SHE:002864)

SHE:002864 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	1,197	1,095	1,169	1,102	823.44	419.3
Cash & Short-Term Investments	1,197	1,095	1,169	1,102	823.44	419.3
Cash Growth	2.59%	-6.37%	6.11%	33.83%	96.38%	9.77%
Accounts Receivable	482.71	547.28	494.59	476.42	538.41	446.38
Other Receivables	27.13	10.07	2.12	3.07	2.13	2.55
Receivables	509.83	557.35	496.71	479.49	540.54	448.93
Inventory	109.87	110.82	95.58	77.63	94.63	66.77
Other Current Assets	11.47	39.71	9.86	18.67	23.33	21.45
Total Current Assets	1,828	1,803	1,772	1,678	1,482	956.45
Property, Plant & Equipment	426.44	439.04	438.21	371.7	353.74	275.04
Long-Term Investments	9.97	10.08	10.21	9.71	9.89	-
Other Intangible Assets	49.38	50.13	51.35	52.76	54.9	56.33
Long-Term Deferred Tax Assets	19.64	9.35	4.89	7.22	16.63	20.2
Long-Term Deferred Charges	6.16	4.39	3.12	2.87	1.31	0.02
Other Long-Term Assets	7.03	7.03	0.71	2.96	12.36	22.13
Total Assets	2,347	2,323	2,280	2,125	1,931	1,330

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	103.14	127.57	107.92	91.43	121.67	66.01
Accrued Expenses	9.46	194.74	187.96	181.38	215.43	176.72
Short-Term Debt	50	-	50	100	150.46	87.2
Current Portion of Long-Term Debt	0.84	98.5	1	-	247.62	13
Current Portion of Leases	-	0.38	0.31	0.39	1.41	2.03
Current Income Taxes Payable	24.84	10.52	8.66	9.11	14.73	17.21
Current Unearned Revenue	7.86	4.21	3.68	5.53	13.26	4.7
Other Current Liabilities	302.8	88.23	86.59	92.57	138.11	70.69
Total Current Liabilities	498.93	524.15	446.11	480.41	902.68	437.55
Long-Term Debt	1	-	98.5	-	27.35	40.35
Long-Term Leases	1.53	1.95	2.33	2.11	0.33	1.32
Long-Term Unearned Revenue	107.89	107.65	95.9	91.25	52.83	41.4
Long-Term Deferred Tax Liabilities	-	-	-	-	-	2.35
Total Liabilities	609.35	633.75	642.84	573.76	983.18	522.97

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	106.28	106.28	106.28	106.28	86.71	86.67
Additional Paid-In Capital	810	813.9	816.64	817.78	259.43	271.67
Retained Earnings	834.11	791.73	737.25	640.06	548.96	463.19
Treasury Stock	-15.07	-25.08	-24.95	-15.07	-15.07	-30.15
Comprehensive Income & Other	-	-	-	-	49.62	-
Total Common Equity	1,735	1,687	1,635	1,549	929.65	791.38
Minority Interest	2.13	2.2	1.97	2.21	17.95	15.82
Shareholders' Equity	1,737	1,689	1,637	1,551	947.6	807.21
Total Liabilities & Equity	2,347	2,323	2,280	2,125	1,931	1,330

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	53.37	100.83	152.14	102.49	427.16	143.9
Net Cash (Debt)	1,144	994.06	1,017	999.52	396.28	275.41
Net Cash Growth	12.62%	-2.28%	1.77%	152.22%	43.89%	-1.78%
Net Cash Per Share	8.42	7.31	7.48	7.87	3.53	2.48
Filing Date Shares Outstanding	138.65	137.68	137.68	136.7	124.54	111.21
Total Common Shares Outstanding	138.65	137.68	137.68	136.7	111.26	111.21
Working Capital	1,329	1,279	1,325	1,197	579.27	518.89
Book Value Per Share	12.52	12.25	11.88	11.33	8.36	7.12
Tangible Book Value	1,686	1,637	1,584	1,496	874.75	735.05
Tangible Book Value Per Share	12.16	11.89	11.50	10.95	7.86	6.61
Buildings	-	447.01	398.37	331.9	329.36	152.82
Machinery	-	176.05	144.4	134.72	125.41	60.38
Construction In Progress	-	6.75	56.05	29.31	3.85	152.18

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 9, 2026

Data Sources Report a data error